Research / ATR / Fundamental state Inspectable configuration
State dimensions Filing 0001558370-18-001077 General Corporate
Debt relative to revenue 21th Own-history percentile · N=14
Evidence method Level · gp.fundamentals.debt_to_revenue
48.24% · OPTIONAL · VALID
Capex intensity 71th Own-history percentile · N=14
Evidence method Level · gp.fundamentals.capex_revenue_ratio
6.34% · OPTIONAL · VALID
Operating cash generation RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
13.15% · OPTIONAL · NOT_ENOUGH_HISTORY
Revenue growth 100th Own-history percentile · N=10
Evidence method Yoy · gp.fundamentals.revenue
5.94% · CORE · VALID
Inventory pressure 21th Own-history percentile · N=14
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
13.66% · OPTIONAL · VALID
Gross margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.gross_margin
29.25% · CORE · NOT_ENOUGH_HISTORY
Operating margin 50th Own-history percentile · N=14
Evidence method Level · gp.fundamentals.operating_margin
13.02% · CORE · VALID
R&D intensity RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
2.76% · OPTIONAL · NOT_ENOUGH_HISTORY
SBC intensity 57th Own-history percentile · N=14
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.77% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 35 states Self-history eligible
Dec 31, 2018 6/9 normalized Level 3 Mar 31, 2019 6/7 normalized Level 3 Jun 30, 2019 6/7 normalized Level 3 Sep 30, 2019 7/7 normalized Level 3 Dec 31, 2019 7/9 normalized Level 3 Mar 31, 2020 7/7 normalized Level 3 Jun 30, 2020 7/7 normalized Level 3 Sep 30, 2020 7/7 normalized Level 3 Mar 31, 2021 7/7 normalized Level 3 Jun 30, 2021 7/7 normalized Level 3 Sep 30, 2021 7/7 normalized Level 3 Dec 31, 2021 7/8 normalized Level 3 Mar 31, 2022 7/7 normalized Level 3 Jun 30, 2022 7/7 normalized Level 3 Sep 30, 2022 7/7 normalized Level 3 Dec 31, 2022 8/8 normalized Level 3 Mar 31, 2023 7/7 normalized Level 3 Jun 30, 2023 7/7 normalized Level 3 Sep 30, 2023 7/7 normalized Level 3 Sep 30, 2026 7/7 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 203.66%
Current 48.24%
Delta -155.43% Capex Intensity Decreased
Previous 8.66%
Current 6.34%
Delta -2.32% Cash Generation Decreased
Previous 18.62%
Current 13.15%
Delta -5.47% Growth Increased
Previous 5.87%
Current 5.94%
Delta 0.07% Inventory Pressure Decreased
Previous 51.80%
Current 13.66%
Delta -38.14% Profitability Increased
Previous 12.88%
Current 13.02%
Delta 0.14% Sbc Intensity Increased
Previous 0.53%
Current 0.77%
Delta 0.24% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.